{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:05:58Z","timestamp":1792033558283,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["europeanneuropsychopharmacology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.euroneuro.2015.01.001","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T16:29:48Z","timestamp":1422894588000},"page":"441-453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression"],"prefix":"10.1016","volume":"25","author":[{"given":"Alexander","family":"Kautzky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Baldinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Souery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Mendlewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Zohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Serretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"Lanzenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2015.01.001_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000343388","article-title":"TPH1, MAOA, serotonin receptor 2A and 2C genes in citalopram response: possible effect in melancholic and psychotic depression","volume":"67","author":"Arias","year":"2013","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ajmg.10099","article-title":"The 5-HT(2A) receptor gene 102T\/C polymorphism is associated with suicidal behavior in depressed patients","volume":"105","author":"Arias","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib3","article-title":"Impact of COMT genotype on serotonin-1A receptor binding investigated with PET","author":"Baldinger","year":"2013","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3758\/CABN.6.1.79","article-title":"Variant BDNF (Val66Met) impact on brain structure and function","volume":"6","author":"Bath","year":"2006","journal-title":"Cogn., Affect. Behav. Neurosci."},{"issue":"5","key":"10.1016\/j.euroneuro.2015.01.001_bib5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/15622975.2013.804195","volume":"14","author":"Bauer","year":"2013","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/070674370705200108","article-title":"Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods","volume":"52","author":"Berlim","year":"2007","journal-title":"Can. J. Psychiatry Rev. Can. Psychiatr."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib7","doi-asserted-by":"crossref","first-page":"e93379","DOI":"10.1371\/journal.pone.0093379","article-title":"Exploiting SNP correlations within random forest for genome-wide association studies","volume":"9","author":"Botta","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/NMD.0b013e3182a5c06e","article-title":"Prevalence of psychotic symptoms in those with melancholic and nonmelancholic depression","volume":"201","author":"Caldieraro","year":"2013","journal-title":"J. Nerv. Mental Dis."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib9","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1109\/TCBB.2011.46","article-title":"Methods for identifying SNP interactions: a review on variations of Logic Regression, Random Forest and Bayesian logistic regression","volume":"8","author":"Chen","year":"2011","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform.\/IEEE, ACM"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib10","doi-asserted-by":"crossref","DOI":"10.3109\/13651501.2014.894073","article-title":"Lack of influence of rs4680 (COMT) and rs6276 (DRD2) on diagnosis and clinical outcomes in patients with major depression","author":"Chiesa","year":"2014","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib11","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.neuroscience.2006.11.030","article-title":"Calcineurin (protein phosphatase 2B) is involved in the mechanisms of action of antidepressants","volume":"144","author":"Crozatier","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ajmg.b.32184","article-title":"Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research.","volume":"162B","author":"Fabbri","year":"2013","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet.: Off. Publ. Int. Soc. Psychiatr. Genet."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/tpj.2014.15","article-title":"PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway","author":"Fabbri","year":"2014","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2174\/1389450111314050004","article-title":"Genetics of serotonin receptors and depression: state of the art","volume":"14","author":"Fabbri","year":"2013","journal-title":"Current Drug Targets"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib15","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1469-1809.2009.00511.x","article-title":"Evaluating the ability of tree-based methods and logistic regression for the detection of SNP\u2013SNP interaction","volume":"73","author":"Garcia-Magarinos","year":"2009","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib16","doi-asserted-by":"crossref","unstructured":"Gratten, J., Wray, N., Keller, M., Visscher, P., 2014. Large-scale genomics unveils the genetic architecture of psychiatric disorders. Nat. Neurosci.. 17(6), 782\u2013790.","DOI":"10.1038\/nn.3708"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pnpbp.2013.04.009","article-title":"Monoamine neurocircuitry in depression and strategies for new treatments","volume":"45","author":"Hamon","year":"2013","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-0028-1094412","article-title":"Therapy-resistant depressions: symptoms and syndromes. contributions to symptomatology and syndromes","volume":"7","author":"Heimann","year":"1974","journal-title":"Pharmakopsychiatr., Neuro-Psychopharmakol."},{"issue":"Suppl. 1","key":"10.1016\/j.euroneuro.2015.01.001_bib19","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1111\/j.1471-4159.2007.04716.x","article-title":"Dissecting polysialic acid and NCAM functions in brain development","volume":"103","author":"Hildebrandt","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib20","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.biopsych.2011.11.030","article-title":"A polymorphism associated with depressive disorders differentially regulates brain derived neurotrophic factor promoter IV activity","volume":"71","author":"Hing","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib21","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/WNR.0b013e32832eb708","article-title":"5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression","volume":"20","author":"Illi","year":"2009","journal-title":"Neuroreport"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2478\/s13380-013-0103-8","article-title":"The role of neurotrophins in major depressive disorder","volume":"4","author":"Jiang","year":"2013","journal-title":"Transl. Neurosci."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/archpsyc.64.3.356","article-title":"Serotonin receptor 2A gene and the influence of childhood maternal nurturance on adulthood depressive symptoms","volume":"64","author":"Jokela","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/sj.npp.1300578","article-title":"Association of serotonin 5-HT2A receptor binding and the T102C polymorphism in depressed and healthy Caucasian subjects","volume":"30","author":"Khait","year":"2005","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YIC.0b013e32833d18f8","article-title":"Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder","volume":"26","author":"Kocabas","year":"2011","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/YIC.0b013e328338b884","article-title":"The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study","volume":"25","author":"Kocabas","year":"2010","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib27","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neuroimage.2013.08.036","article-title":"Gray matter and intrinsic network changes in the posterior cingulate cortex after selective serotonin reuptake inhibitor intake","volume":"84","author":"Kraus","year":"2014","journal-title":"NeuroImage"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib28","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2741\/4153","article-title":"PPP3CC feedback regulates IP3-Ca2+ pathway through preventing ITPKC degradation","volume":"18","author":"Li","year":"2013","journal-title":"Front. Biosci."},{"issue":"3","key":"10.1016\/j.euroneuro.2015.01.001_bib29","first-page":"18","article-title":"Classification and regression by randomforest","volume":"2","author":"Liaw","year":"2002","journal-title":"R News"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib30","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.pnpbp.2009.06.015","article-title":"Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder","volume":"33","author":"Lin","year":"2009","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib31","unstructured":"Maechler, M., Rousseeuw, P., Struyf, A., Hubert, M., Hornik, K., 2014. Cluster: cluster analysis basics and extensions. R package version 1.15.2."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-244X-5-1","article-title":"Duloxetine in the treatment of major depressive disorder: a comparison of efficacy in patients with and without melancholic features","volume":"5","author":"Mallinckrodt","year":"2005","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/YIC.0b013e32833c4ceb","article-title":"Identification of clinical factors associated with resistance to antidepressants in bipolar depression: results from an European Multicentre Study","volume":"25","author":"Mendlewicz","year":"2010","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.psc.2007.01.001","article-title":"A critical overview of the pharmacologic management of treatment-resistant depression","volume":"30","author":"Nierenberg","year":"2007","journal-title":"Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pnpbp.2013.05.011","article-title":"Pharmacogenetics in major depression: a comprehensive meta-analysis","volume":"45","author":"Niitsu","year":"2013","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2014.04.013","article-title":"Converging translational evidence for the involvement of the serotonin 2A receptor gene in major depressive disorder","author":"Petit","year":"2014","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1503\/jpn.100059","article-title":"Pharmacogenetics of antidepressant response","volume":"36","author":"Porcelli","year":"2011","journal-title":"J. Psychiatry Neurosci.: JPN"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib38","first-page":"903","article-title":"[Association between polymorphisms of ins\/del in the 5-HTT gene and T102C in the 5HTR2A gene and the drug response for escitalopram and nortriptyline in depressed patients]","volume":"42","author":"Rajewska-Rager","year":"2008","journal-title":"Psychiatr. Pol."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2350-14-33","article-title":"Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes","volume":"14","author":"Sacchetti","year":"2013","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.euroneuro.2011.08.007","article-title":"The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder\u2014a European multicenter study","volume":"22","author":"Schosser","year":"2012","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib41","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.euroneuro.2012.02.006","article-title":"European Group for the Study of Resistant Depression (GSRD)\u2014where have we gone so far: review of clinical and genetic findings","volume":"22","author":"Schosser","year":"2012","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib42","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.biopsych.2008.05.005","article-title":"Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications","volume":"64","author":"Sen","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"Suppl. 20","key":"10.1016\/j.euroneuro.2015.01.001_bib43","first-page":"S22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0924-977X(98)00004-2","article-title":"Treatment resistant depression: methodological overview and operational criteria","volume":"9","author":"Souery","year":"1999","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2015.01.001_bib45","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4088\/JCP.v68n0713","article-title":"Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study","volume":"68","author":"Souery","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib46","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.biopsych.2012.10.030","article-title":"Contribution of common genetic variants to antidepressant response","volume":"73","author":"Tansey","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"Suppl. 13","key":"10.1016\/j.euroneuro.2015.01.001_bib47","first-page":"S23","article-title":"When at first you don\u05f3t succeed: sequential strategies for antidepressant nonresponders","volume":"58","author":"Thase","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib48","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010","volume":"382","author":"Whiteford","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib49","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00213-012-2823-9","article-title":"Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway","volume":"225","author":"Yu","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2015.01.001_bib50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.schres.2013.01.020","article-title":"Genetic variation in BDNF is associated with antipsychotic treatment resistance in patients with schizophrenia","volume":"146","author":"Zhang","year":"2013","journal-title":"Schizophr. Res."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X15000024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X15000024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T03:17:01Z","timestamp":1651115821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X15000024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0924977X15000024"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2015.01.001","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725444199.793531019","asserted-by":"object"}]},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2015.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}